Do you have type 2 diabetes and are currently struggling to control your glucose levels?
This clinical research study is evaluating an experimental treatment for type 2 diabetics.
Would you like to take part?
As a volunteer in a research study, you’ll receive study-related medical care from the study doctor and regular follow-up of your health to monitor the effectiveness of the care you’ll receive. The results of this research will be used to find out if the investigational medication being studied will be of benefit to others struggling to manage type 2 diabetes, and whether it will be made widely available to all Canadians. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Have been diagnosed with type 2 diabetes greater than or equal to (≥) 180 days prior to the day of screening
- Have been treated with any of the following non-insulin glucose-lowering medication(s) or combination regimen(s) at the time of screening:
- Metformin, Sulfonylureas, Meglitinides (glinides), dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose cotransporter-2 (SGLT2) inhibitors, Thiazolidinediones, Alpha-glucosidase inhibitors, Oral combination products (for the allowed individual oral antidiabetic drugs), Oral or injectable glucagon-like peptide-1 (GLP-1) receptor agonists and Injectable dual glucose-dependent insulinotropic polypeptides (GIP) and GLP-1 receptor agonist.
- Have need of intensification with basal insulin, as indicated at the discretion of the investigator.
- Have recorded HbA1c value ≥7% within the last 90 days prior to randomization.
You may not qualify to participate if you:
- Have any known or suspected hypersensitivity to study intervention(s) or related products.
- Have any previous participation in this study. Participation is defined as signed informed consent.
- Are a female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using adequate contraceptive method.
- Have previously participated (i.e., received any study intervention) in any interventional clinical study within 90 days before screening.
- Have any disorder which in the investigator’s opinion might jeopardize your safety.
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.
